Science Blockchain Releases Q1 2019 SCI Token NAV

Santa Monica, CA — April 5, 2019 — Science Blockchain Pte Ltd., the premier startup studio investing in and building blockchain technology companies, today announces that the NAV of each SCI token as of April 5, 2019, is $0.48, based on the NAV of the underlying VC fund, Science Blockchain Holdings, LP.

The overall digital asset market conditions are the primary driver of the $0.01 increase from the $0.47 NAV reported for the period ending January 2, 2019.

This past quarter, Science Blockchain made an investment in RealBlocks, a blockchain platform that allows real estate sponsors to seamlessly raise capital from investors worldwide. It was highlighted in CoinDesk, Fortune, The Real Deal, Inman, PE Hub, Silicon Angle and more. The team also announced its partnership with HedgeBase, simplified, secure and white-labeled trading solutions for over-the-counter desks, exchanges and banks, which was covered by CryptoNinjas. The Science Blockchain team currently has multiple ventures in stealth including a new digital collectible experience.

For upcoming distributions, Science Blockchain has been informed by VideoCoin, which is creating video infrastructure on the blockchain, that it plans to distribute tokens May 25, 2019. Science Blockchain expects to distribute the VID tokens it receives to the SCI token holders shortly after receipt. The Science Blockchain team will be providing details of future distributions to token holders through its usual communication channels. Note that distributions will only be made to holders of upgraded SCI2 tokens.

Because these new ventures, token sales and distributions are underway, Science Blockchain is currently carrying these investments at cost in line with our accounting policies. When and if there is reliable pricing data for these assets, we will mark them to market which will then be reflected in our future NAV reporting.

The Science Blockchain portfolio includes the following:

• Cash
• Bitcoin (BTC)
• Ethereum (ETH)
• EOS (EOS)
• EOS DAC (EOSDAC)
• BitClave (CAT)
• WePower (WPR)
• PolySwarm (NCT)
• SpringRole (SPRING)
• Mainframe (MFT)
• Aventus (AVT)
• SMRT (future tokens)
• 8gig (future tokens)
• Splyt (future tokens)
• VideoCoin (future tokens)
• GG Project Foundation (future tokens)
• Teal Aura (equity)
• Glacier Formation (equity)
• HedgeBase (equity)
• March Media Technology (equity)
• Fund3 (equity)
• RealBlocks (equity)
• FanDragon (equity)
• Dmail Inc (equity)
• Wave Financial Group (convertible debt)

The Science Blockchain team appreciates the trust and support of the SCI token holders and is committed to earning that trust each day through executing on its investment strategy.

As a reminder, all original SCI tokens, including those remaining on Tokenhub, are now frozen. Upgraded SCI tokens are available through the Securitize platform and the upgrade process is now open to all Science Blockchain investors at https://science.securitize.io. All SCI token holders who received their tokens via Tokenhub as part of the original issuance of the SCI tokens have received an email at the email address provided during the original SCI issuance process that contains a unique link to access their SCI Token Upgrade Dashboard.

The second token upgrade was completed in February 2019, and the third upgrade will be scheduled in the coming weeks. Reminder for token holders to complete the token upgrade process if they have not already done so. Further, token holders will need to have upgraded SCI tokens (SCI2 tokens) in a registered wallet in order to receive portfolio company tokens that were held on Tokenhub and future portfolio company token distributions. Please visit https://science.securitize.io for more information and to complete the upgrade process as soon as possible.

2018 Portfolio Company Token Distribution History

Please find below a table of portfolio company tokens distributed to SCI token holders in 2018. As a reminder, for token holders that held SCI tokens on Tokenhub, you will be receiving portfolio company tokens in the coming weeks provided that you hold upgraded tokens (SCI2 tokens) in a registered wallet. For token holders that received portfolio company tokens directly in a wallet that you control, you can view the number of portfolio tokens in your wallet via https://etherscan.io/. You can also find historical pricing data at https://coinmarketcap.com/.

SCI Token holders are encouraged to register and visit https://www.science-inc.com/blockchain.html for current information.

About Science BlockchaIn

Science has been helping entrepreneurs build successful businesses for more than six years, during which time it has funded or founded more than 85 companies, and has had $1.3B in aggregate portfolio company exits. Science Blockchain, the first incubator in the world to be funded by its own tokenized compliant securities offering (token: SCI), intends to continue this history of successful company building by helping incredible blockchain entrepreneurs create and scale the software giants of the next century. We do this in three primary ways: 1) incubating promising early stage blockchain ventures, 2) engaging on a very limited and selective basis, with companies looking to take advantage of the possibilities presented by tokenized economies, and 3) investing in compliant private offerings of blockchain businesses. The unique token structure of SCI allows us to distribute 70% of the total tokens that Science Blockchain receives through our incubation and investment strategies directly to the SCI token holders. For more details, please visit https://www.science-inc.com/blockchain.html.

Disclaimer: This document contains certain forward-looking statements, relating to Science Inc.’s business, which can be identified by the use of forward-looking terminology such as “promising”, “plans”, “anticipated”, “will”, “project”, “believe”, “forecast”, “expected”, “estimated”, “targeting”, “aiming”, “set to”, “potential”, “seeking to”, “goal”, “could provide”, “intends”, “is being developed”, “could be”, “on track”, or similar expressions, or by express or implied discussions regarding potential filings or marketing approvals, or potential future sales of product candidates. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated or expected. Science Inc. is providing this information as of the date of this document and does not assume any obligation to update any forward-looking statements contained in this document as a result of new information, future events or developments or otherwise.